Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.

Linke, Axel; Chandrasekhar, Jaya; Sartori, Samantha; Lefevre, Thierry; van Belle, Eric; Schaefer, Ulrich; Tchetche, Didier; Sardella, Gennaro; Webb, John; Colombo, Antonio; Windecker, Stephan; Vogel, Birgit; Farhan, Serdar; Sorrentino, Sabato; Sharma, Madhav; Snyder, Clayton; Asgar, Anita; Dumonteil, Nicolas; Tamburino, Corrado; Hink, Ulrich; Violini, Roberto; Stella, Pieter; Bernstein, Debra; Deliargyris, Efthymios; Hengstenberg, Christian; Baber, Usman; Mehran, Roxana; Anthopoulos, Prodromos; Dangas, George.
Catheter Cardiovasc Interv; 90(6): 1016-1026, 2017 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-28498562